Sutton Wealth Advisors’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,105
Closed -$41.1K 1324
2022
Q4
$41.1K Buy
2,105
+19
+0.9% +$371 0.02% 446
2022
Q3
$50.3K Sell
2,086
-16
-0.8% -$493 0.02% 377
2022
Q2
$66.1K Buy
2,102
+9
+0.4% +$326 0.03% 315
2022
Q1
$92.1K Sell
2,093
-10
-0.5% -$429 0.03% 264
2021
Q4
$91.5K Buy
2,103
+17
+0.8% +$666 0.03% 279
2021
Q3
$65.3K Sell
2,086
-19
-0.9% -$748 0.02% 332
2021
Q2
$89.1K Sell
2,105
-149
-7% -$5.8K 0.03% 269
2021
Q1
$84.7K Hold
2,254
0.03% 265
2020
Q4
$61K Sell
2,254
-2
-0.1% -$51 0.03% 308
2020
Q3
$56.6K Hold
2,256
0.03% 282
2020
Q2
$17.2K Hold
2,256
0.01% 582
2020
Q1
$20.6K Hold
2,256
0.01% 471
2019
Q4
$11.7K Hold
2,256
0.01% 773
2019
Q3
$13.1K Buy
+2,256
New +$10.1K 0.01% 714
2019
Q1
Sell
-1,062
Closed -$6.72K 1205
2018
Q4
$6.72K Sell
1,062
-148
-12% -$1.54K ﹤0.01% 830
2018
Q3
$20K Hold
1,210
0.01% 584
2018
Q2
$20.2K Hold
1,210
0.01% 586
2018
Q1
$18.8K Buy
+1,210
New +$21.6K 0.01% 594

Other funds holding ACH

Sutton Wealth Advisors's ACH Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Accendra Health (ACH) in Q1 2023, closing a stake of 2,105 shares — an estimated $41.1K sold.

Sutton Wealth Advisors first reported a position in ACH in Q1 2018 and held it in 18 quarters. The position peaked at $92.1K in Q1 2022. 218 funds tracked by Wall St. Rank hold ACH as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Accendra Health position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 2,105 Accendra Health shares in Q1 2023, an estimated $41.1K.
  • Sutton Wealth Advisors first reported a position in Accendra Health in Q1 2018 and held it in 18 quarters.
  • Sutton Wealth Advisors's Accendra Health position peaked at $92.1K in Q1 2022.
  • 218 funds tracked by Wall St. Rank held Accendra Health as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.